Utilizing left atrial strain to identify patients at risk for atrial fibrillation on ibrutinib.
Arushi SinghNadia El HangoucheKatherine McGeeFei-Fei GongRobert LentzJoseph FeinglassNausheen AkhterPublished in: Echocardiography (Mount Kisco, N.Y.) (2020)
Age, ibrutinib dose, E/e', and PALS on pre-treatment echocardiogram were significantly associated with development of IRAF. On multivariate regression analyses, age, PALS, and PACS remained significantly associated with IRAF. Impaired LA mechanics add to the assessment of patients at risk for IRAF.